Skip to main content

Want a detailed portfolio tracker?

BioAffinity Technologies (BIAF) P/E (2022 - 2026)

BioAffinity Technologies (BIAF) P/E from Sep 30, 2022 to Jul 21, 2026. The TTM BioAffinity Technologies (BIAF) P/E is -0.10. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of BioAffinity Technologies (BIAF)

YearP/EChange
2026-0.10-10.82%
2025-0.11-91.62%
2024-1.30-26.26%
2023-1.77-35.06%
2022-2.72N/A

Comparison BioAffinity Technologies (BIAF) P/E with competitors

BioAffinity Technologies (BIAF) P/E is -0.10.

TickerNameP/EUpside
ADVBAdvanced Biomed Inc1.05-1177.47%
MBAICheckCap Ltd1.71-1860.03%
FONRFonar Corp15.48-16005.79%
QGENQiagen NV20.03-20683.16%
DGXQuest Diagnostics Inc22.47-23194.18%
LHLaboratory Corp Of America Holdings23.87-24630.50%
IQVIQVIA Holdings Inc25.28-26081.31%
AAgilent Technologies Inc26.96-27802.80%
TMOThermo Fisher Scientific Inc31.53-32499.90%
MTDMettler-Toledo International Inc32.45-33446.86%
MEDPMedpace Holdings Inc32.55-33549.11%
DHRDanaher Corp38.55-39718.40%
IDXXIdexx Laboratories Inc40.58-41796.17%
ILMNIllumina Inc44.12-45438.40%
RVTYRevvity Inc52.68-54236.27%
VCYTVeracyte Inc53.71-55295.55%
ICLRIcon Plc57.45-59138.28%
SHCSotera Health Company74.08-76230.88%
WATWaters Corp102.79-105725.26%